Form D · Biotechnology
EBS ACQ, LLC
Norwood, MA · CIK 0002034656
Offering snapshot reported Aug 30, 2024 · SEC filing
- Reported sold
- $1.8M Offering amount: $1.8M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 12, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 30, 2024 | Initial | $1,800,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-522879
Source: Form D, filed Aug 30, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian Michael Fox | Director |
| Stephen Gatto | Director, Executive |
| Gerardus Jacobus Hoetmer | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
29 Royal Court Suite 100
Norwood, MA, 02062
Norwood, MA, 02062